Clinical Trial Update: Autologous Adipose-derived Stem Cells (ASCs) for the Treatment of Perianal Fistula in Crohn Disease: A Pilot Study [Phase 2]

View source ↗

Summary

Describes a Phase 2 pilot clinical trial evaluating autologous adipose-derived stem cells for treating perianal fistula in Crohn's disease; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Perianal Fistula

Drugs mentioned

• Autologous adipose-derived stem cells (adipose-derived stem cells)

Snippet

Sponsor: Papa Giovanni XXIII Hospital | Conditions: Perianal Fistula, Crohn Disease | Phase 2 | Status: UNKNOWN